Bioceltix S.A. (WSE:BCX)
Poland flag Poland · Delayed Price · Currency is PLN
77.80
-1.20 (-1.52%)
Jan 8, 2026, 5:00 PM CET

Bioceltix Ratios and Metrics

Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021
Period Ending
Jan '26 Dec '24 Dec '23 Dec '22 Dec '21
389431372133172
Market Cap Growth
2.60%16.07%179.48%-22.49%-
Enterprise Value
365394357130-
Last Close Price
79.0087.6090.0038.8052.20
PB Ratio
14.4111.2335.5125.8228.60
P/TBV Ratio
14.4111.2335.5125.8228.60
Debt / Equity Ratio
0.020.020.020.060.09
Inventory Turnover
84.10126.03---
Quick Ratio
8.5112.085.231.943.41
Current Ratio
8.8312.345.242.683.42
Return on Equity (ROE)
-43.22%-60.95%-175.28%-160.02%-
Return on Assets (ROA)
-25.14%-34.54%-85.92%-70.62%-
Return on Capital (ROIC)
-26.86%-37.80%-108.90%-93.47%-
Return on Capital Employed (ROCE)
-55.10%-39.00%-132.30%-165.70%-70.00%
Earnings Yield
-3.80%-3.45%-3.68%-6.71%-2.56%
FCF Yield
-3.37%-4.13%-4.09%-6.19%-2.35%
Buyback Yield / Dilution
-25.36%-15.76%-17.48%-5.54%-
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.